Pyrido[2,3-d]pyrimidine-2,4-diamines as pde2 inhibitors
申请人:Beyer A. Thomas
公开号:US20070135457A1
公开(公告)日:2007-06-14
The invention provides compounds of formula (I)
prodrugs thereof, and the pharmaceutically acceptable salts of the compounds or prodrugs, wherein n, X, and Y are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof.
PYRIDO[2,3-D]PYRIMIDINE-2,4-DIAMINES AS PDE 2 INHIBITORS
申请人:Pfizer Products Incorporated
公开号:EP1697356B1
公开(公告)日:2008-02-27
[EN] PYRIDO[2,3-D]PYRIMIDINE-2,4-DIAMINES AS PDE 2 INHIBITORS<br/>[FR] PYRIDO[2,3-D]PYRIMIDINE-2,4-DIAMINES EN TANT QU'INHIBITEURS DE LA PDE 2
申请人:PFIZER PROD INC
公开号:WO2005061497A1
公开(公告)日:2005-07-07
The invention provides compounds of formula (I) prodrugs thereof, and the pharmaceutically acceptable salts of the compounds or prodrugs, wherein n, X, and Y are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof.